OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 639, Issue 1-2, 2008, Pages 45-54

  Hatt, Lotte ^a   Loft, Steffen ^a   Risom, Lotte ^a   Møller, Peter ^a   Sørensen, Mette ^b   Raaschou Nielsen, Ole ^b   Overvad, Kim ^c   Tjønneland, Anne ^b   Vogel, Ulla ^d,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e ROSKILDE UNIVERSITY   (Denmark)

Author keywords

8 oxo dG; BER gene expression; Lung cancer; Polymorphism; Prospective

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE 1; BIOLOGICAL MARKER; DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE; MESSENGER RNA; NEI ENDONUCLEASE 1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; URINARY EXCRETION; WILD TYPE;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; COHORT STUDIES; CYSTEINE; DNA GLYCOSYLASES; DNA REPAIR; FEMALE; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, MESSENGER; SERINE; SMOKING;

EID: 39249085710     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.11.002     Document Type: Article

References (46)

1. Evans M.D., Dizdaroglu M., and Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 567 (2004) 1-61
2. Loft S., and Moller P. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid. Redox Signal. 8 (2006) 1021-1031
3. Hainaut P., and Pfeifer G.P. Patterns of p53 G → T transversions in lung cancers reflect the primary mutagenic signature of DNA damage by tobacco smoke. Carcinogenesis 22 (2001) 367-374
4. Smart D.J., Chipman J.K., and Hodges N.J. Activity of OGG1 variants in the repair of pro-oxidant-induced 8-oxo-2′-deoxyguanosine. DNA Repair (Amst) 5 (2006) 1337-1345
5. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De P.G., Soucek P., and Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis (2006)
6. Janssen K., Schlink K., Gotte W., Hippler B., Kaina B., and Oesch F. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat. Res. 486 (2001) 207-216
7. Lee A.J., Hodges N.J., and Chipman J.K. Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7,8-dihydro-2′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 497-505
8. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review. Am. J. Epidemiol. 162 (2005) 925-942
9. Hung R.J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Chabrier A., Borel S., Hall J., and Boffetta P. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 97 (2005) 567-576
10. Kohno T., Kunitoh H., Toyama K., Yamamoto S., Kuchiba A., Saito D., Yanagitani N., Ishihara S., Saito R., and Yokota J. Association of the OGG1 Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. 97 (2006) 724-728
11. Vogel U., Nexo B.A., Wallin H., Overvad K., Tjonneland A., and Raaschou-Nielsen O. No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem. Genet. 42 (2004) 453-460
12. Ito H., Hamajima N., Takezaki T., Matsuo K., Tajima K., Hatooka S., Mitsudomi T., Suyama M., Sato S., and Ueda R. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J. Epidemiol. 12 (2002) 258-265
13. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., and Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl. Cancer Inst. 95 (2003) 1312-1319
14. Wei Q., Cheng L., Hong W.K., and Spitz M.R. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 56 (1996) 4103-4107
15. Parsons J.L., Zharkov D.O., and Dianov G.L. NEIL1 excises 3′ end proximal oxidative DNA lesions resistant to cleavage by NTH1 and OGG1. Nucleic Acids Res. 33 (2005) 4849-4856
16. Mokkapati S.K., Wiederhold L., Hazra T.K., and Mitra S. Stimulation of DNA glycosylase activity of OGG1 by NEIL1: functional collaboration between two human DNA glycosylases. Biochemistry 43 (2004) 11596-11604
17. Das A., Hazra T.K., Boldogh I., Mitra S., and Bhakat K.K. Induction of the human oxidized base-specific DNA glycosylase NEIL1 by reactive oxygen species. J. Biol. Chem. 280 (2005) 35272-35280
18. Sieber O.M., Lipton L., Crabtree M., Heinimann K., Fidalgo P., Phillips R.K., Bisgaard M.L., Orntoft T.F., Aaltonen L.A., Hodgson S.V., Thomas H.J., and Tomlinson I.P. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N. Engl. J. Med. 348 (2003) 791-799
19. Russo M.T., De L.G., Degan P., Parlanti E., Dogliotti E., Barnes D.E., Lindahl T., Yang H., Miller J.H., and Bignami M. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumour-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 64 (2004) 4411-4414
20. Xie Y., Yang H., Cunanan C., Okamoto K., Shibata D., Pan J., Barnes D.E., Lindahl T., McIlhatton M., Fishel R., and Miller J.H. Deficiencies in mouse Myh and Ogg1 result in tumour predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumours. Cancer Res. 64 (2004) 3096-3102
21. Speina E., Arczewska K.D., Gackowski D., Zielinska M., Siomek A., Kowalewski J., Olinski R., Tudek B., and Kusmierek J.T. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small cell lung cancer patients. J. Natl. Cancer Inst. 97 (2005) 384-395
22. Loft S., Svoboda P., Kasai H., Tjonneland A., Vogel U., Moller P., Overvad K., and Raaschou-Nielsen O. Prospective study of 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 27 (2006) 1245-1250
23. Risom L., Moller P., Vogel U., Kristjansen P.E., and Loft S. X-ray-induced oxidative stress: DNA damage and gene expression of HO-1, ERCC1 and OGG1 in mouse lung. Free Radic. Res. 37 (2003) 957-966
24. Cheng L., Spitz M.R., Hong W.K., and Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 21 (2000) 1527-1530
25. Tjonneland A.M., Olsen A., Boll K., Stripp C., Christensen J., Engholm G., and Overvad O.K. Study design, exposure variables, and socio-economic determinants of participation in Diet, Caner and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand. J. Public Health 35 (2007) 432-441
26. Vogel U., Nexo B.A., Tjonneland A., Wallin H., Hertel O., and Raaschou-Nielsen O. ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutat. Res. 593 (2006) 88-96
27. Hanaoka T., Yamano Y., Hashimoto H., Kagawa J., and Tsugane S. A preliminary evaluation of intra- and interindividual variations of hOGG1 messenger RNA levels in peripheral blood cells as determined by a real-time polymerase chain reaction technique. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1255-1258
28. Thellin O., Zorzi W., Lakaye B., De B.B., Coumans B., Hennen G., Grisar T., Igout A., and Heinen E. Housekeeping genes as internal standards: use and limits. J. Biotechnol. 75 (1999) 291-295
29. Barlow W.E., Ichikawa L., Rosner D., and Izumi S. Analysis of case-cohort designs. J. Clin. Epidemiol. 52 (1999) 1165-1172
30. Barlow W.E. Robust variance estimation for the case-cohort design. Biometrics 50 (1994) 1064-1072
31. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6 (1995) 356-365
32. Risom L., Dybdahl M., Bornholdt J., Vogel U., Wallin H., Moller P., and Loft S. Oxidative DNA damage and defence gene expression in the mouse lung after short-term exposure to diesel exhaust particles by inhalation. Carcinogenesis 24 (2003) 1847-1852
33. Dybdahl M., Risom L., Moller P., Autrup H., Wallin H., Vogel U., Bornholdt J., Daneshvar B., Dragsted L.O., Weimann A., Poulsen H.E., and Loft S. DNA adduct formation and oxidative stress in colon and liver of Big Blue rats after dietary exposure to diesel particles. Carcinogenesis 24 (2003) 1759-1766
34. Loft S., Poulsen H.E., Vistisen K., and Knudsen L.E. Increased urinary excretion of 8-oxo-2′-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat. Res. 441 (1999) 11-19
35. Loft S., and Poulsen H.E. Markers of oxidative damage to DNA: antioxidants and molecular damage. Methods Enzymol. 300 (1999) 166-184
36. Mo J., Xia Y., Wade T.J., Schmitt M., Le X.C., Dang R., and Mumford J.L. Chronic arsenic exposure and oxidative stress: OGG1 expression and arsenic exposure, nail selenium, and skin hyperkeratosis in Inner Mongolia. Environ. Health Perspect. 114 (2006) 835-841
37. Sorensen M., Raaschou-Nielsen O., Hansen R.D., Tjonneland A., Overvad K., and Vogel U. Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic. Res. 40 (2006) 885-891
38. Vogel U., Nexo B.A., Olsen A., Thomsen B., Jacobsen N.R., Wallin H., Overvad K., and Tjonneland A. No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 170-171
39. Vogel U., Olsen A., Wallin H., Overvad K., Tjonneland A., and Nexo B.A. No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1680-1681
40. Hashimoto T., Uchida K., Okayama N., Imate Y., Suehiro Y., Hamanaka Y., Ueyama Y., Yamashita H., and Hinoda Y. Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma. Mol. Carcinog. 45 (2006) 344-348
41. Aka P., Mateuca R., Buchet J.P., Thierens H., and Kirsch-Volders M. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low-dose ionising radiations?. Mutat. Res. 556 (2004) 169-181
42. Elahi A., Zheng Z., Park J., Eyring K., McCaffrey T., and Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23 (2002) 1229-1234
43. Lan Q., Mumford J.L., Shen M., Demarini D.M., Bonner M.R., He X., Yeager M., Welch R., Chanock S., Tian L., Chapman R.S., Zheng T., Keohavong P., Caporaso N., and Rothman N. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25 (2004) 2177-2181
44. Hoffmann H., and Speit G. Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and the micronucleus test. Mutat. Res. 581 (2005) 105-114
45. Paz-Elizur T., Elinger D., Leitner-Dagan Y., Blumenstein S., Krupsky M., Berrebi A., Schechtman E., and Livneh Z. Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals. DNA Repair (Amst) (2006)
46. Vogel U., Moller P., Dragsted L., Loft S., Pedersen A., and Sandstrom B. Interindividual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers. Carcinogenesis 23 (2002) 1505-1509